.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Colorcon
Queensland Health
Federal Trade Commission
Fish and Richardson
Dow
Covington
McKesson
Chubb

Generated: December 18, 2017

DrugPatentWatch Database Preview

Romark Company Profile

« Back to Dashboard

What is the competitive landscape for ROMARK, and when can generic versions of ROMARK drugs launch?

ROMARK has two approved drugs.

There are three US patents protecting ROMARK drugs.

There are one hundred and twenty-three patent family members on ROMARK drugs in forty-two countries.

Summary for Romark

International Patents:123
US Patents:3
Tradenames:1
Ingredients:1
NDAs:2
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
RomarkALINIAnitazoxanideFOR SUSPENSION;ORAL021498-001Nov 22, 2002RXYesYes► Subscribe► Subscribe► Subscribe
RomarkALINIAnitazoxanideTABLET;ORAL021497-001Jul 21, 2004RXYesYes► Subscribe► SubscribeY► Subscribe
RomarkALINIAnitazoxanideFOR SUSPENSION;ORAL021498-001Nov 22, 2002RXYesYes► Subscribe► Subscribe► Subscribe
RomarkALINIAnitazoxanideFOR SUSPENSION;ORAL021498-001Nov 22, 2002RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Romark

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
RomarkALINIAnitazoxanideFOR SUSPENSION;ORAL021498-001Nov 22, 2002► Subscribe► Subscribe
RomarkALINIAnitazoxanideFOR SUSPENSION;ORAL021498-001Nov 22, 2002► Subscribe► Subscribe
RomarkALINIAnitazoxanideFOR SUSPENSION;ORAL021498-001Nov 22, 2002► Subscribe► Subscribe
RomarkALINIAnitazoxanideTABLET;ORAL021497-001Jul 21, 2004► Subscribe► Subscribe
RomarkALINIAnitazoxanideTABLET;ORAL021497-001Jul 21, 2004► Subscribe► Subscribe
RomarkALINIAnitazoxanideFOR SUSPENSION;ORAL021498-001Nov 22, 2002► Subscribe► Subscribe
RomarkALINIAnitazoxanideTABLET;ORAL021497-001Jul 21, 2004► Subscribe► Subscribe
RomarkALINIAnitazoxanideFOR SUSPENSION;ORAL021498-001Nov 22, 2002► Subscribe► Subscribe
RomarkALINIAnitazoxanideFOR SUSPENSION;ORAL021498-001Nov 22, 2002► Subscribe► Subscribe
RomarkALINIAnitazoxanideFOR SUSPENSION;ORAL021498-001Nov 22, 2002► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Romark

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,886,013 Antiviral composition► Subscribe
5,387,598 Composition and galenic formulation suitable for combatting affections of the lower abdomen► Subscribe
6,051,576 Means to achieve sustained release of synergistic drugs by conjugation► Subscribe
6,020,353 2-(hydroxy)-N-(5-nitro-2-thiazolyl) benzamide► Subscribe
5,859,038 Method for treatment of helicobacter pylori infections► Subscribe
5,856,348 Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide► Subscribe
5,578,621 Benzamide derivatives► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Romark Drugs

Country Document Number Estimated Expiration
New Zealand500149► Subscribe
Eurasian Patent Organization002920► Subscribe
Poland336805► Subscribe
Czech Republic9602959► Subscribe
Japan2001503067► Subscribe
World Intellectual Property Organization (WIPO)9850035► Subscribe
Czech Republic9903911► Subscribe
Bulgaria103958► Subscribe
Hungary0003330► Subscribe
Norway995406► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Farmers Insurance
Teva
Covington
Express Scripts
Merck
Boehringer Ingelheim
US Department of Justice
Deloitte
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot